Login to Your Account


Lumos seeking to light the way with drug for ultra-rare CTD

By Marie Powers
Staff Writer

Monday, February 24, 2014
The ultra-rare disease creatine transporter deficiency (CTD) wreaks havoc on its patient population of young boys. The x-linked autism spectrum disorder prevents the transport of creatine – a nitrogenous organic acid that serves as fuel for the body’s cells – into the brain, causing patients to suffer seizures, speech delay, behavioral abnormalities and severe cognitive impairment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription